FDA issued a Warning Letter to Bristol Myers Squibb Holdings Pharma., Ltd. on 8/30/2010 for a previous inspection.
483 Bristol-Myers Squibb Holdings Pharma Liability Company Mar 2011

483 Bristol-Myers Squibb Holdings Pharma Liability Company Mar 2011

Jose Cruz Gonzalez FDA, Raquel Gonzalez Rivera FDA, Wanda Torres FDA$119.00 - Available Now

FDA investigators audited the Bristol-Myers Squibb Holdings Pharma Liability Company - Manati, PR, United States facility and issued 1 inspectional observation (via FDA 483) on 28 Mar 2011.

Product details

  • Category: Human Drugs / Medical Devices & Rad Health
  • Number of Observations: 1
  • Inspection end: 28 Mar 2011
  • Location: Manati, United States
  • FEI: 2650089
Add To Cart